Image

Prehabilitation Protocol for Head and Neck Cancer Patients

Prehabilitation Protocol for Head and Neck Cancer Patients

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this research is to help researchers understand the barriers, supports, and preferences for prehabilitation. Prehabilitation in this study means head and neck cancer patients will receive nutritional counseling sessions and attend exercise programs before and during radiotherapy/chemoradiotherapy treatment.

Eligibility

Aim 2 Inclusion Criteria: Implement prehabilitation prescription protocol and evaluate the feasibility and acceptability of the prehabilitation prescription protocol in a sample of HNC patients.

  1. Age 18 to 80 years old
  2. Patients with a diagnosis of non-metastatic squamous cell carcinoma originating in the head and neck (oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx).
  3. Patients with a plan for curative radiation therapy (RT) / chemoradiation therapy (CRT) at SCCC\ - \Patients who underwent surgery for the HNC are still eligible.
  4. Clearance for exercise by the medical team.
  5. Patients who do not have their first treatment scheduled within 3 weeks at the time of recruitment.
  6. An English or Spanish speaker.

Aim 2 Exclusion Criteria:

  1. A patient with a metastatic cancer.
  2. A patient who cannot complete the baseline assessment and/or start prehabilitation by the initiation of RT/CRT.
  3. Any contraindication for diet change or exercising as determined by a physician.
  4. Engaging in \>150 minutes of moderate to vigorous physical activity on average per week for the prior month.
  5. A patient who is not an English or Spanish speaker.
  6. History of dementia or major psychiatric disease which would interfere with study.
  7. History of recent (≤1 yr) stroke, myocardial infarction, or congestive heart failure
  8. Eastern Cooperative Oncology Group (ECOG) equal to or higher than 2.

Study details
    Head and Neck Cancer

NCT07318220

University of Miami

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.